Skip to main content

Vor Biopharma Inc.

VOR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001817229

In the last 90 days, Vor Biopharma Inc. insiders filed 0 open-market purchases and 1 sale; 102 institutions reported holding it in 13F filings for Q2 2026, worth $893.0M in total; no superinvestor holds it.

Q1 2025 vs. Q4 2024

How the institutions holding Vor Biopharma Inc. changed between Q4 2024 and Q1 2025.

All holders in Q1 2025All holders in Q4 2024

13F holders of VOR: Q4 2024 compared with Q1 2025
MeasureQ4 2024Q1 2025Change
Holders5246−6
Shares60.9M60.1M−800.7K (−1.3%)
Value$67.6M$43.2M−$24.5M (−36.2%)

New holders (10)

Institutions that held Vor Biopharma Inc. at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to VOR in Q1 2025
InstitutionSharesValue% of portfolio
Jane Street Group, LLC194,756$139.7K0.00%
Omers Administration Corp139,600$100.2K0.00%
DGS Capital Management, LLC55,300$39.7K0.01%
Qube Research & Technologies Ltd48,196$34.6K0.00%
Jain Global LLC24,054$17.3K0.00%
Schonfeld Strategic Advisors LLC13,425$9.63K0.00%
Gsa Capital Partners LLP11,859$9.00K0.00%
Catalyst Funds Management Pty Ltd10,764$7.72K0.00%
Chicago Partners Investment Group LLC12,731$6.82K0.00%
UBS Group AG8,455$6.07K0.00%

Sold out (16)

Institutions that held Vor Biopharma Inc. at the end of Q4 2024 and filed for Q1 2025 without it.

Institutions that sold out of VOR in Q1 2025
InstitutionShares, Q4 2024Value, Q4 2024
Lynx1 Capital Management LP637,218$707.3K
Ensign Peak Advisors, Inc329,378$365.6K
Citadel Advisors LLC200,405$222.4K
Acadian Asset Management LLC86,685$95.0K
XTX Topco Ltd71,788$79.7K
Virtu Financial LLC54,470$60.0K
LMR Partners LLP51,111$56.7K
Point72 Asia (Singapore) Pte. Ltd.28,090$31.2K
Two Sigma Advisers, LP27,500$30.5K
Cubist Systematic Strategies, LLC16,102$17.9K
Two Sigma Securities, LLC10,069$11.2K
Wedbush Securities Inc10,000$11.0K
Eagle Bay Advisors LLC150$167
Point72 (DIFC) Ltd26$29
Citigroup Inc6$7
NBC Securities, Inc.1$1